{"name":"Inmode","slug":"inmode","ticker":"INMD","exchange":"NASDAQ","domain":"inmodemd.com","description":"InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduc","hq":"Yokneam, Israel","founded":0,"employees":"660","ceo":"","sector":"Medical Aesthetics / Energy","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":13.99,"stockChange":-0.05,"stockChangePercent":-0.36,"marketCap":"$851M","metrics":{"revenue":374638016,"revenueGrowth":5.3,"grossMargin":77.8,"rdSpend":0,"netIncome":87192000,"cash":537158976,"dividendYield":0,"peRatio":10.4,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":370495000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":370495000},{"period":"2024-12-31","value":394818000},{"period":"2023-12-31","value":492048000},{"period":"2022-12-31","value":454271000}],"grossProfit":290970000,"grossProfitHistory":[{"period":"2025-12-31","value":290970000},{"period":"2024-12-31","value":317066000},{"period":"2023-12-31","value":411340000},{"period":"2022-12-31","value":380786000}],"rdSpend":13319000,"rdSpendHistory":[{"period":"2025-12-31","value":13319000},{"period":"2024-12-31","value":13137000},{"period":"2023-12-31","value":13410000},{"period":"2022-12-31","value":12425000}],"sgaSpend":192264000,"operatingIncome":85387000,"operatingIncomeHistory":[{"period":"2025-12-31","value":85387000},{"period":"2024-12-31","value":112531000},{"period":"2023-12-31","value":195660000},{"period":"2022-12-31","value":197854000}],"netIncome":93831000,"netIncomeHistory":[{"period":"2025-12-31","value":93831000},{"period":"2024-12-31","value":181275000},{"period":"2023-12-31","value":197919000},{"period":"2022-12-31","value":161520000}],"eps":1.43,"epsHistory":[{"period":"2025-12-31","value":1.43},{"period":"2024-12-31","value":2.25},{"period":"2023-12-31","value":2.3},{"period":"2022-12-31","value":1.89}],"cash":302543000,"cashHistory":[{"period":"2025-12-31","value":302543000},{"period":"2024-12-31","value":155329000},{"period":"2023-12-31","value":144411000},{"period":"2022-12-31","value":97540000}],"totalAssets":766429000,"totalLiabilities":83231000,"totalDebt":8227000,"equity":683198000,"operatingCashflow":85257000,"operatingCashflowHistory":[{"period":"2025-12-31","value":85257000},{"period":"2024-12-31","value":132664000},{"period":"2023-12-31","value":176826000},{"period":"2022-12-31","value":181578000}],"capex":-972000,"capexHistory":[{"period":"2025-12-31","value":-972000},{"period":"2024-12-31","value":-669000},{"period":"2023-12-31","value":-705000},{"period":"2022-12-31","value":-1575000}],"freeCashflow":84285000,"dividendsPaid":null,"buybacks":-127444000,"employees":660,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":47954000,"ebit":10056000,"ebitda":10231000,"period":"2026-03-31","revenue":82017000,"epsBasic":0.18,"netIncome":11562000,"rdExpense":3542000,"epsDiluted":0.18,"grossProfit":61552000,"operatingIncome":10056000},{"sga":51800000,"ebit":25991000,"ebitda":26165000,"period":"2025-12-31","revenue":103854000,"epsBasic":0.43,"netIncome":27025000,"rdExpense":3509000,"epsDiluted":0.42,"grossProfit":81300000,"operatingIncome":25991000},{"sga":47869000,"ebit":20897000,"ebitda":21053000,"period":"2025-09-30","revenue":93165000,"epsBasic":0.35,"netIncome":21863000,"rdExpense":3543000,"epsDiluted":0.34,"grossProfit":72309000,"operatingIncome":20897000},{"sga":50197000,"ebit":22881000,"ebitda":23072000,"period":"2025-06-30","revenue":95602000,"epsBasic":0.42,"netIncome":26742000,"rdExpense":3372000,"epsDiluted":0.42,"grossProfit":76450000,"operatingIncome":22881000},{"sga":42398000,"ebit":15618000,"ebitda":15792000,"period":"2025-03-31","revenue":77874000,"epsBasic":0.26,"netIncome":18201000,"rdExpense":2895000,"epsDiluted":0.26,"grossProfit":60911000,"operatingIncome":15618000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":13.99,"previousClose":14.04,"fiftyTwoWeekHigh":16.74,"fiftyTwoWeekLow":12.72,"fiftyTwoWeekRange":"12.72 - 16.74","fiftyDayAverage":13.84,"twoHundredDayAverage":14.46,"beta":1.98,"enterpriseValue":357820032,"forwardPE":9.5,"priceToBook":1.3,"priceToSales":2.27,"enterpriseToRevenue":0.95,"enterpriseToEbitda":4.44,"pegRatio":0,"ebitda":80521000,"ebitdaMargin":21.5,"freeCashflow":43626624,"operatingCashflow":86599000,"totalDebt":4829000,"debtToEquity":0.7,"currentRatio":8.8,"returnOnAssets":6.9,"returnOnEquity":13.6,"analystRating":"2.8 - Hold","recommendationKey":"hold","numberOfAnalysts":4,"targetMeanPrice":15.5,"targetHighPrice":19,"targetLowPrice":14,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":11.9,"institutionHeldPercent":53,"sharesOutstanding":60808750,"floatShares":54968667,"sharesShort":3304849,"shortRatio":4.9,"shortPercentOfFloat":5.4,"epsTrailing":1.35,"epsForward":1.48,"revenuePerShare":5.92,"bookValue":10.78,"officers":[{"age":57,"name":"Dr. Michael  Kreindel","title":"Co-Founder, CTO & Director"},{"age":44,"name":"Mr. Michael  Dennison","title":"President of North America"},{"age":72,"name":"Mr. Moshe  Mizrahy","title":"Co-Founder, CEO & Director"},{"age":null,"name":"Mr. Matt  Rodgers","title":"Vice President of Sales of Canada"},{"age":null,"name":"Mr. Brandon  Nye","title":"Vice President of Sales of West US"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.inmodemd.com","phone":"972 4 909 6313"}}